Filter
561
Filtered Results: 561
Text search:
World
Health
Organization
WH=
Featured
Recommendations
76
New Publications
74
Language
Document type
Studies & Reports
178
Guidelines
142
No document type
96
Manuals
56
Strategic & Response Plan
47
Training Material
16
Fact sheets
11
Situation Updates
6
Brochures
3
Resource Platforms
3
Infographics
3
Countries / Regions
Global
70
Latin America and the Carribbean
20
Western and Central Europe
13
Africa
12
Kenya
10
South–East Asia Region
10
India
10
South Africa
9
Ethiopia
8
Nepal
7
Ukraine
7
Uganda
7
Ghana
6
Philippines
6
Middle East and North Africa
6
Sierra Leone
5
Nigeria
5
West and Central Africa
5
East and Southern Africa
5
Asia
4
Eastern Europe and Central Asia
4
Bangladesh
4
Eastern Europe
4
Russia
4
Syria
3
Burkina Faso
3
Tanzania
3
Congo, Democratic Republic of
3
Lebanon
3
Brazil
3
Sudan
3
Yemen
3
Timor Leste/ East Timor
2
Rwanda
2
Kazakhstan
2
Kyrgyzstan
2
Western Pacific Region
2
Vietnam
2
Moldova
2
Indonesia
2
Liberia
2
Tajikistan
1
North Korea
1
Colombia
1
Thailand
1
Mexico
1
Lesotho
1
Turkey
1
China
1
Albania
1
Laos
1
Senegal
1
Estonia
1
Afghanistan
1
Malawi
1
Mongolia
1
Haiti
1
Jordan
1
Germany
1
Paraguay
1
North America
1
Turkmenistan
1
Belarus
1
Argentina
1
Sri Lanka
1
Romania
1
Poland
1
Bhutan
1
Botswana
1
Zambia
1
Iraq
1
Somalia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
145
Clinical Guidelines
69
Public Health
63
Women & Child Health
46
Key Resources
42
Pharmacy & Technologies
11
Capacity Building
8
Toolboxes
COVID-19
73
AMR
38
Mental Health
34
Caregiver
34
Planetary Health
34
TB
33
Rapid Response
28
NTDs
28
NCDs
27
HIV
23
Pharmacy
20
Global Health Education
19
Conflict
15
Disability
12
Refugee
9
Health Financing Toolbox
8
Natural Hazards
6
Cholera
5
Ebola & Marburg
4
Malaria
4
Zika
4
Social Ethics
2
Specific Hazards
1
Polio
1
Risk of spill-over of EVD to Uganda has been categorised as very high. On 28 September 2018, WHO elevated the risk at the regional level which includes Uganda from ‘high’ to ‘very high’. Uganda has a very long and largely porous border with the DRC. High population movements across the borde...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
The development of the Country Cooperation Strategy (CCS) was based on a consultative and participatory process with strong commitment and support from the Ministry of Health of Ghana. The CCS draws on lessons from the implementation of the first, and second generation CCSs, the country focus strate...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health-relevant policies and public services that engage communities. The response to malaria must be an i...
10–11 May 2016, Catania, Italy
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
Toolkit regarding Zika Virus
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
This document is intended for a wide audience including national and local policymakers, implementers and managers of national and local maternal and child health programmes, non-governmental and other organizations and professional societies involved in the planning and management of maternal and c...
The risk communication and community engagement (RCCE) competency framework is a resource that details the essential behaviours and activities necessary for effective communication and engagement with communities before, during and after public health emergencies. The purpose of this framework is to...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
